Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD

Xuting Wang1, Hye-Youn Cho1, Michelle R Campbell1

  • 1Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Building 101, MD C3-03, PO Box 12233, 111 TW Alexander Dr., Research Triangle Park, NC, 27709, USA.

Clinical Epigenetics
|April 28, 2022
PubMed

Insights

Bronchopulmonary dysplasia (BPD) in premature infants is linked to gestational age and birth weight. Early epigenetic biomarkers, including nucleated red blood cell levels, offer insights into BPD development.

Area of Science:

  • Neonatal Medicine
  • Epigenetics
  • Genomics

Background:

  • Bronchopulmonary dysplasia (BPD) is a critical lung disease affecting premature infants, often resulting from supplemental oxygen therapy.
  • Despite advances in neonatal care, BPD incidence is rising, with limited therapeutic interventions for prevention and treatment.
  • Understanding early risk factors and biomarkers is crucial for improving outcomes in preterm neonates.

Purpose of the Study:

  • To investigate the association between gestational age, birth weight, and blood cell composition in preterm infants.
  • To identify early epigenetic biomarkers linked to the development of bronchopulmonary dysplasia (BPD).
  • To explore the relationship between cord blood methylation profiles and BPD risk.

Main Methods:

  • Cord blood DNA methylation arrays (Illumina 450K) were used to estimate blood cell-type composition.
  • Multivariable robust regression identified CpG sites associated with BPD risk.
  • Epigenome-wide association studies (EWAS) and transcriptome analysis were performed on cord blood samples.

Main Results:

  • Gestational age and birth weight were significantly associated with BPD development and oxygen supplementation needs.
  • Nucleated red blood cell (NRBC) percentage showed associations with birth weight, gestational age, and DNA hypomethylation.
  • EWAS identified numerous differentially methylated CpGs in cord blood linked to BPD, enriched in lung maturation and hematopoiesis pathways.
  • Elevated stochastic epigenetic mutation burden was observed in infants who developed BPD.

Conclusions:

  • Nucleated red blood cell content significantly influences DNA methylation profiles in preterm cord blood.
  • Epigenetic analysis reveals potential biological pathways involved in the pathogenesis of BPD.
  • Early identification of epigenetic biomarkers may aid in predicting and potentially preventing BPD.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K